Abstract
Background
The long-term prognosis after acute kidney injury (AKI) is variable. It is unclear how the prognosis of AKI and its relationship to prognostic factors (baseline kidney function, AKI severity, prior AKI episodes, and recovery of kidney function) change as follow-up progresses.
Study Design
Observational cohort study.
Setting & Participants
The Grampian Laboratory Outcomes Morbidity and Mortality Study II (GLOMMS-II) is a large regional population cohort with complete serial biochemistry and outcome data capture through data linkage. From GLOMMS-II, we followed up 17,630 patients hospitalized in 2003 through to 2013.
Original language | English |
---|---|
Pages (from-to) | 18-28 |
Number of pages | 11 |
Journal | American Journal of Kidney Diseases |
Volume | 69 |
Issue number | 1 |
Early online date | 21 Aug 2016 |
DOIs | |
Publication status | Published - 1 Jan 2017 |
Keywords
- Acute kidney injury (AKI)
- chronic kidney disease (CKD)
- baseline kidney function
- survival
- mortality
- epidemiology
- outcomes
- prognosis
- AKI recovery
- acute on chronic kidney disease
Fingerprint
Dive into the research topics of 'Intermediate and Long-Term Outcomes of Survivors of Acute Kidney Injury Episodes: A Large Population-Based Cohort Study'. Together they form a unique fingerprint.Profiles
-
Corri Black
- Aberdeen Centre For Health Data Science
- School of Medicine, Medical Sciences & Nutrition, Applied Health Sciences - Personal Chair (Clinical)
- School of Medicine, Medical Sciences & Nutrition, Grampian Data Safe Haven (DaSH)
- School of Medicine, Medical Sciences & Nutrition, Chronic Disease Research Group
- School of Medicine, Medical Sciences & Nutrition, Farr Aberdeen
Person: Clinical Academic
-
Simon Sawhney
- School of Medicine, Medical Sciences & Nutrition, Applied Health Sciences - Senior Clinical Lecturer
- Aberdeen Centre For Health Data Science
- School of Medicine, Medical Sciences & Nutrition, Farr Aberdeen
- School of Medicine, Medical Sciences & Nutrition, Grampian Data Safe Haven (DaSH)
Person: Clinical Academic